Try our beta test site
22 studies found for:    therapeutic vaccine | Open Studies | HIV
Show Display Options
RSS Create an RSS feed from your search for:
therapeutic vaccine | Open Studies | HIV
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting iHIVARNA Clinical Trial in HIV Infected Individuals
Condition: HIV Infections
Interventions: Biological: iHIVARNA-01;   Biological: TriMix;   Biological: Placebo
2 Recruiting Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Ad5-gag;   Biological: Placebo
3 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
4 Not yet recruiting An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
Condition: Hiv
Interventions: Biological: GTU-MultiHIV B-clade vaccine;   Biological: MVA HIV-B HIV vaccine;   Biological: Placebo 1: Sodium Chloride;   Biological: Placebo 2:S08 buffer
5 Not yet recruiting REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Condition: HIV/AIDS
Intervention: Biological: REMUNE
6 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Interventions: Biological: Gardasil;   Drug: Placebo
7 Not yet recruiting REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study
Condition: HIV
Intervention: Biological: IR103
8 Recruiting A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals
Condition: Hepatitis C Infection
Interventions: Biological: AdCh3NSmut1;   Biological: MVA-NSmut
9 Recruiting Improving Identification of Social Harm Among Substance Abusers in HIV Trials
Conditions: Social Harms in Substance Users in HIV Trials;   Audio Computer Assisted Self-administered Questionnaire
Intervention:
10 Recruiting Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV (vCP2438);   Biological: Bivalent Subtype C gp120/MF59;   Biological: Placebo
11 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
12 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study
Condition: HIV Infections
Interventions: Drug: Dolutegravir;   Drug: Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamid Fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Rilpivirine;   Drug: Lamivudine;   Drug: tenofovir;   Drug: Emtricitabine;   Drug: Abacavir
13 Recruiting Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
Condition: HIV-1 Infection
Interventions: Drug: Vorinostat;   Biological: AGS-004
14 Recruiting Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Conditions: Liver Diseases, Alcoholic;   Alcoholism;   HIV;   Hepatitis C
Interventions: Other: Integrated Stepped Care (ISC);   Other: Treatment as Usual
15 Recruiting Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Bedaquiline;   Drug: Delamanid;   Drug: Dolutegravir
16 Not yet recruiting Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 Infected Patients
Condition: HIV Infection
Interventions: Biological: DCV3;   Biological: DCV3 with PEG-INF;   Biological: Placebo;   Biological: Placebo with PEG-INF
17 Recruiting Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy
Condition: HIV
Interventions: Drug: triple therapy;   Drug: dual therapy
18 Recruiting Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults
Condition: Rabies
Intervention: Biological: rabies vaccine
19 Recruiting CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Conditions: Bone Marrow Failure Syndrome;   Severe Aplastic Anemia;   Severe Congenital Neutropenia;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Schwachman Diamond Syndrome;   Primary Immunodeficiency Syndromes;   Acquired Immunodeficiency Syndromes;   Histiocytic Syndrome;   Familial Hemophagocytic Lymphocytosis;   Lymphohistiocytosis;   Macrophage Activation Syndrome;   Langerhans Cell Histiocytosis (LCH);   Hemoglobinopathies;   Sickle Cell Disease;   Sickle Cell-beta-thalassemia
Intervention: Biological: CD34 Stem Cell Selection Therapy
20 Recruiting Safety and Virologic Effect of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously to HIV-Infected Adults
Condition: HIV-1
Intervention: Biological: VRC-HIVMAB080-00-AB (VRC01LS)

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.